Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Lemper

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Diabetologia|June 20, 2016
A combination of cytokines EGF and CNTF protects the functional beta cell mass in mice with short-term hyperglycaemiaMarie Lemper, Sofie De Groef, Geert Stangé, et al.
Cancer Chemotherapy and Pharmacology|July 28, 2023
An IQ consortium analysis of starting dose selection for oncology small molecule first-in-patient trials suggests an alternative NOAEL-based method can be safe while reducing time to the recommended phase 2 doseBart A Jessen, Paul Cornwell, Sean Redmond, et al.
Physiological Reviews|May 3, 2018
(Re)generating Human Beta Cells: Status, Pitfalls, and PerspectivesLuc Baeyens, Marie Lemper, Willem Staels, et al.
Reproductive Toxicology (Elmsford, N.Y.)|March 6, 2025
Subcutaneous zilucoplan: Evaluation of reproductive toxicologyMarie Lemper, C Marc Luetjens, Antje Fuchs, et al.
Diabetologia|April 8, 2016
Sources of beta cells inside the pancreasSofie De Groef, Willem Staels, Naomi Van Gassen, et al.
Mabs|December 15, 2018
Single cell-produced and in vitro-assembled anti-FcRH5/CD3 T-cell dependent bispecific antibodies have similar in vitro and in vivo propertiesAyse Meric Ovacik, Ji Li, Marie Lemper, et al.
Nature Biotechnology|November 19, 2013
Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic miceLuc Baeyens, Marie Lemper, Gunter Leuckx, et al.
Nature Biotechnology|February 19, 2020
Retraction Note: Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic miceLuc Baeyens, Marie Lemper, Gunter Leuckx, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Diabetologia|June 20, 2016
A combination of cytokines EGF and CNTF protects the functional beta cell mass in mice with short-term hyperglycaemiaMarie Lemper, Sofie De Groef, Geert Stangé, et al.
Cancer Chemotherapy and Pharmacology|July 28, 2023
An IQ consortium analysis of starting dose selection for oncology small molecule first-in-patient trials suggests an alternative NOAEL-based method can be safe while reducing time to the recommended phase 2 doseBart A Jessen, Paul Cornwell, Sean Redmond, et al.
Physiological Reviews|May 3, 2018
(Re)generating Human Beta Cells: Status, Pitfalls, and PerspectivesLuc Baeyens, Marie Lemper, Willem Staels, et al.
Reproductive Toxicology (Elmsford, N.Y.)|March 6, 2025
Subcutaneous zilucoplan: Evaluation of reproductive toxicologyMarie Lemper, C Marc Luetjens, Antje Fuchs, et al.
Diabetologia|April 8, 2016
Sources of beta cells inside the pancreasSofie De Groef, Willem Staels, Naomi Van Gassen, et al.
Mabs|December 15, 2018
Single cell-produced and in vitro-assembled anti-FcRH5/CD3 T-cell dependent bispecific antibodies have similar in vitro and in vivo propertiesAyse Meric Ovacik, Ji Li, Marie Lemper, et al.
Nature Biotechnology|November 19, 2013
Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic miceLuc Baeyens, Marie Lemper, Gunter Leuckx, et al.
Nature Biotechnology|February 19, 2020
Retraction Note: Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic miceLuc Baeyens, Marie Lemper, Gunter Leuckx, et al.
Pageof 1